ReviewCurrent opinion in supportive and palliative care2019
The role of splanchnic congestion and the intestinal microenvironment in the pathogenesis of advanced heart failure.
Review in Current opinion in supportive and palliative care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 33 citations in OpenAlex.
- Programming the beating heart with polymer catalysis: a therapeutic microenvironment revolution.Journal of nanobiotechnology · 2026Review
- Prognostic value of echocardiography-estimated right atrial pressure beyond the MAGGIC risk score in heart failure patients.Frontiers in cardiovascular medicine · 2026Article
- Study on influencing factors of anxiety symptoms and its association with nutritional condition in elderly heart failure patients.Frontiers in nutrition · 2026Article
- Gastroparesis in heart failure: temporal trends, clinical correlates, and outcomes in a large national cohort.Translational gastroenterology and hepatology · 2026Article
- Effect ofFrontiers in medicine · 2026Article
- Review
- Mechanisms of exercise in preventing cardiovascular diseases: Insights from gut microbiota characteristics in pathological states of cardiovascular diseases.Reviews in endocrine & metabolic disorders · 2025Review
- Iron Deficiency Treatment in Heart Failure-Challenges and Therapeutic Solutions.Journal of clinical medicine · 2025Review
- Role of Gut Microbial Metabolites in Ischemic and Non-Ischemic Heart Failure.International journal of molecular sciences · 2025Review
- Role of Gut Microbial Metabolites in Cardiovascular Diseases-Current Insights and the Road Ahead.International journal of molecular sciences · 2024Review
- Thrombosis and Thrombotic Risk in Athletes.Journal of clinical medicine · 2024Review
- Evaluation value of ultrasound on gastrointestinal function in patients with acute heart failure.Frontiers in cardiovascular medicine · 2024Article
- Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?International journal of molecular sciences · 2023Review
- Effects of Modified Dietary Fiber from Fresh Corn Bracts on Obesity and Intestinal Microbiota in High-Fat-Diet Mice.Molecules (Basel, Switzerland) · 2023Article
- Tricuspid regurgitation, right ventricular function, and renal congestion: a cardiorenal triangle.Frontiers in cardiovascular medicine · 2023Review
- Relationship between disorders of the intestinal microbiota and heart failure in infants with congenital heart disease.Frontiers in cellular and infection microbiology · 2023Article
- Review
- Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.Circulation research · 2022Review
- Role of the Gut Microbiota in Glucose Metabolism During Heart Failure.Frontiers in cardiovascular medicine · 2022Article
- Trimethylamine N-oxide and outcomes in patients hospitalized with acute heart failure and preserved ejection fraction.ESC heart failure · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
purpose of reviewRight-sided heart failure, which is often present in the setting of advanced heart failure, is associated with cardiac cachexia, the cardiorenal syndrome, and adverse outcomes. Improved understanding of venous congestion of the splanchnic circulation, which may play a key role in the pathogenesis of right-sided heart failure, could lead to novel therapeutics to ameliorate heart failure. Here we provide an overview of right-sided heart failure, splanchnic hemodynamics, fluid homeostasis, and the intestinal microenvironment. We review recent literature to describe pathophysiologic mechanisms and possible therapeutics. RECENT
findingsSeveral possible mechanisms centered around upregulation of sodium-hydrogen exchanger-3 (NHE3) may form a causal link between right ventricular dysfunction, splanchnic congestion, and worsening heart failure. These include an anaerobic environment in enterocytes, resulting in reduced intracellular pH; increased sodium absorption by the gut via NHE3; decreased pH at the intestinal brush border thus altering the gut microbiome profile; increased bacterial synthesis of trimethylamine N-oxide; and decreased bacterial synthesis of short-chain fatty acids causing abnormal intestinal barrier function. SUMMARY: Splanchnic congestion in the setting of right-sided heart failure may serve an important role in the pathogenesis of advanced heart failure, and further exploration of these mechanisms may lead to new therapeutic advances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.